Documente Academic
Documente Profesional
Documente Cultură
Suppose we have a test statistic for predicting the presence or absence of disease.
True Disease Status Pos Neg
Test Criterion
Pos Neg
Suppose we have a test statistic for predicting the presence or absence of disease.
True Disease Status Pos Neg
Test Criterion
Pos Neg
Suppose we have a test statistic for predicting the presence or absence of disease.
True Disease Status Pos Neg
Test Criterion
Pos Neg
TP
TP = True Positive
2009, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Suppose we have a test statistic for predicting the presence or absence of disease.
True Disease Status Pos Neg
Test Criterion
Pos Neg
Suppose we have a test statistic for predicting the presence or absence of disease.
True Disease Status Pos Neg
Test Criterion
Pos Neg
FP
FP = False Positive
2009, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Suppose we have a test statistic for predicting the presence or absence of disease.
True Disease Status Pos Neg
Test Criterion
Pos Neg
Suppose we have a test statistic for predicting the presence or absence of disease.
True Disease Status Pos Neg
Test Criterion
Pos Neg
FN
FN = False Negative
Suppose we have a test statistic for predicting the presence or absence of disease.
True Disease Status Pos Neg
Test Criterion
Pos Neg
Suppose we have a test statistic for predicting the presence or absence of disease.
True Disease Status Pos Neg TN
TN = True Negative
2009, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Test Criterion
Pos Neg
Suppose we have a test statistic for predicting the presence or absence of disease.
True Disease Status Pos Neg
Test Criterion
Pos Neg
TP FN
P
FP TN
N P+ N
True Disease Status Pos Neg Test Pos TP FP Criterion Neg FN TN P N Accuracy = Probability that the test yields a correct result. = (TP+TN) / (P+N)
2009, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
P+ N
Test Criterion
Pos Neg
P N P+ N Sensitivity = Probability that a true case will test positive = TP / P Also referred to as True Positive Rate (TPR) or True Positive Fraction (TPF).
2009, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
True Disease Status Pos Neg Test Pos TP FP Criterion Neg FN TN P N P+ N Specificity = Probability that a true negative will test negative = TN / N Also referred to as True Negative Rate (TNR) or True Negative Fraction (TNF).
2009, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
True Disease Status Pos Neg Test Pos TP FP Criterion Neg FN TN P N P+ N 1-Specificity = Prob that a true negative will test positive = FP / N Also referred to as False Positive Rate (FPR) or False Positive Fraction (FPF).
2009, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
Test Criterion
Pos Neg
True Disease Status Pos Neg TP FP FN TN P N P+ N = Probability that a positive test will truly have disease
= TP / (TP+FP)
Of these properties, only Se and Sp (and hence FPR) are considered invariant test characteristics. Accuracy, PPV, and NPV will vary according to the underlying prevalence of disease. Se and Sp are thus fundamental test properties and hence are the most useful measures for comparing different test criteria, even though PPV and NPV are probably the most clinically relevant properties.
ROC Curves
Now assume that our test statistic is no longer binary, but takes on a series of values (for instance how many of five distinct risk factors a person exhibits). Clinically we make a rule that says the test is positive if the number of risk factors meets or exceeds some threshold (#RF > x) Suppose our previous table resulted from using x = 4. Lets see what happens as we vary x.
ROC Curves
Impact of using a threshold of 3 or more RFs
Test Criterion
Pos Neg
.27 .81
45 55
200 700
200
Se = 27/100 = .45
100 900 1000 .75 Acc = (27+727)/1000 = .75 PPV = 27/200 = .18 .91 NPV = 727/800 = .93
.14
ROC Curves
Summary of all possible options
Threshold 6 5 4 3 2 1 0
As we relax our threshold for defining disease, our true positive rate (sensitivity) increases, but so does the false positive rate (FPR). The ROC curve is a way to visually display this information.
ROC Curves
Summary of all possible options
Threshold 6 5 4 3 2 1 0
x=2
x=4 x=5
The diagonal line shows what we would expect from simple guessing (i.e., pure chance).
ROC Curves
Summary of a more optimal curve
Threshold 6 5 4 3 2 1 0
Note the immediate sharp rise in sensitivity. Perfect accuracy is represented by upper left corner.
ROC Curves
Use and interpretation
The ROC curve allows us to see, in a simple visual display, how sensitivity and specificity vary as our threshold varies. The shape of the curve also gives us some visual clues about the overall strength of association between the underlying test statistic (in this case #RFs that are present) and disease status.
2009, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
ROC Curves
Use and interpretation
The ROC methodology easily generalizes to test statistics that are continuous (such as lung function or a blood gas). We simply fit a smoothed ROC curve through all observed data points.
ROC Curves
Use and interpretation
See demo from www.anaesthetist.com/mnm/stats/roc/index.htm
ROC Curves
Area under the curve (AUC)
The total area of the grid represented by an ROC curve is 1, since both TPR and FPR range from 0 to 1. The portion of this total area that falls below the ROC curve is known as the area under the curve, or AUC.
2009, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
The AUC serves as a quantitative summary of the strength of association between the underlying test statistic and disease status. An AUC of 1.0 would mean that the test statistic could be used to perfectly discriminate between cases and controls. An AUC of 0.5 (reflected by the diagonal 45 line) is equivalent to simply guessing.
The AUC can be shown to equal the MannWhitney U statistic, or equivalently the Wilcoxon rank statistic, for testing whether the test measure differs for individuals with and without disease. It also equals the probability that the value of our test measure would be higher for a randomly chosen case than for a randomly chosen control.
2009, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
controls
cases
TPR
controls
cases TPR
http://gim.unmc.edu/dxtests/roc3.htm .90-1.0 = excellent .80-.90 = good .70-.80 = fair .60-.70 = poor .50-.60 = fail Remember that <.50 is worse than guessing!
2009, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
www.childrens-mercy.org/stats/ask/roc.asp .97-1.0 = excellent .92-.97 = very good .75-.92 = good .50-.75 = fair
ROC Curves
Comparing multiple ROC curves
Suppose we have two candidate test statistics to use to create a binary decision rule. Can we use ROC curves to choose an optimal one?
ROC Curves
Comparing multiple ROC curves
ROC Curves
Comparing multiple ROC curves
ROC Curves
Comparing multiple ROC curves
We can formally compare AUCs for two competing test statistics, but does this answer our question? AUC speaks to which measure, as a continuous variable, best discriminates between cases and controls? It does not tell us which specific cutpoint to use, or even which test statistic will ultimately provide the best cutpoint.
2009, KAISER PERMANENTE CENTER FOR HEALTH RESEARCH
ROC Curves
Choosing an optimal cutpoint The choice of a particular Se and Sp should reflect the relative costs of FP and FN results. What if a positive test triggers an invasive procedure? What if the disease is life threatening and I have an inexpensive and effective treatment? How do you balance these and other competing factors? See excellent discussion of these issues at www.anaesthetist.com/mnm/stats/roc/index.htm
ROC Curves
Generalizations
These techniques can be applied to any binary outcome. It doesnt have to be disease status.
In fact, the use of ROC curves was first introduced during WWII in response to the challenge of how to accurately identify enemy planes on radar screens.
ROC Curves
Final cautionary notes We assume throughout the existence of a gold standard for measuring disease, when in practice no such gold standard exists.
COPD, asthma, even cancer (can we truly rule out the absence of cancer in a given patient?)
As a result, even Se and Sp may not be inherently stable test characteristics, but may vary depending on how we define disease and the clinical context in which it is measured.
Are we evaluating the test in the general population or only among patients referred to a specialty clinic? Incorrect specification of P and N will vary in these two settings.